A detailed history of Perritt Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Perritt Capital Management Inc holds 5,072 shares of ABBV stock, worth $987,974. This represents 0.5% of its overall portfolio holdings.

Number of Shares
5,072
Previous 5,162 1.74%
Holding current value
$987,974
Previous $940,000 7.55%
% of portfolio
0.5%
Previous 0.53%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$154.79 - $180.76 $13,931 - $16,268
-90 Reduced 1.74%
5,072 $869,000
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $1,118 - $1,274
7 Added 0.14%
5,162 $940,000
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $127,280 - $143,347
-925 Reduced 15.21%
5,155 $798,000
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $68,507 - $85,253
-517 Reduced 7.84%
6,080 $819,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $42,081 - $48,463
-291 Reduced 4.22%
6,597 $1.05 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $4,564 - $5,473
-33 Reduced 0.48%
6,888 $1.11 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $7,247 - $8,312
-54 Reduced 0.77%
6,921 $929,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $20,643 - $26,244
-150 Reduced 2.11%
6,975 $1.07 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $102,680 - $127,397
-778 Reduced 9.84%
7,125 $1.16 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $5,908 - $7,476
55 Added 0.7%
7,903 $1.07 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $48,944 - $55,558
460 Added 6.23%
7,848 $847,000
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $192,534 - $214,494
1,830 Added 32.93%
7,388 $832,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $22,506 - $24,776
220 Added 4.12%
5,558 $601,000
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $24,147 - $32,601
-300 Reduced 5.32%
5,338 $572,000
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $41,924 - $49,205
-488 Reduced 7.97%
5,638 $494,000
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $117,392 - $157,088
-1,600 Reduced 20.71%
6,126 $601,000
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $1,574 - $1,893
-25 Reduced 0.32%
7,726 $585,000
Q2 2019

Aug 13, 2019

SELL
$65.7 - $83.98 $1,642 - $2,099
-25 Reduced 0.32%
7,726 $562,000
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $1,642 - $2,099
25 Added 0.32%
7,751 $625,000
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $3,857 - $4,539
-50 Reduced 0.64%
7,751 $625,000
Q4 2018

Feb 08, 2019

SELL
$77.85 - $96.01 $13,623 - $16,801
-175 Reduced 2.19%
7,801 $719,000
Q4 2017

Jan 25, 2018

SELL
$89.56 - $98.21 $8,956 - $9,821
-100 Reduced 1.24%
7,976 $771,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $564,108 - $720,540
8,076
8,076 $718,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Perritt Capital Management Inc Portfolio

Follow Perritt Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.